Invesco Nasdaq Biotechnology ETF holds a quantitatively derived Bronze Morningstar Medalist Rating. The rating reflects that it has scored better than the norm on factors Morningstar research associates with future outperformance relative to category peers.
Invesco Nasdaq Biotechnology ETF IBBQ
Morningstar’s Analysis IBBQ
Will IBBQ outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 45.1
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Gilead Sciences Inc | 8.11 | 9M | Healthcare |
Amgen Inc | 7.69 | 8M | Healthcare |
Vertex Pharmaceuticals Inc | 7.60 | 8M | Healthcare |
Moderna Inc | 5.09 | 5M | Healthcare |
Regeneron Pharmaceuticals Inc | 4.99 | 5M | Healthcare |
Revolution Medicines Inc Ordinary Shares | 2.97 | 3M | Healthcare |
Illumina Inc | 2.77 | 3M | Healthcare |
Biogen Inc | 2.18 | 2M | Healthcare |
Alnylam Pharmaceuticals Inc | 1.97 | 2M | Healthcare |
Roivant Sciences Ltd Ordinary Shares | 1.73 | 2M | Healthcare |